The Effect of Transrectal Ultrasound-guided Prostate Needle Biopsy on Lower Urinary Tract Symptoms
Journal Title: Üroonkoloji Bülteni - Year 2018, Vol 17, Issue 3
Abstract
Objective: To evaluate the effect of transrectal ultrasound-guided prostate biopsy on lower urinary system symptoms. Materials and Methods: The study included 123 patients who underwent ultrasound-guided prostate biopsy between March 2013 and December 2013. Before and at 2, 4, and 8 weeks after the procedure, the patients completed the International Prostate Symptom Score (IPSS) questionnaire. Storage symptoms (questions 2, 4, 7) and voiding/postvoiding symptoms (questions 1, 3, 5, 6) were separately evaluated. The patients with cancer diagnosis were excluded after the week 4. The cancer-free patients were divided into subgroups based on education level and complication status and followed for 8 weeks to assess changes in IPSS and quality of life. Results: IPSS increased significantly at week 2 follow-up of both the cancerous and cancer-free patients (p=0.041 and p<0.01); however, there was no statistically significant difference between the pre-biopsy scores and week 4 scores (p=0.07 and p=0.09). Voiding/postvoiding symptoms also increased significantly at week 2 for both groups (p=0.04 and p<0.01, respectively). IPSS was significantly higher in all subgroups of cancer-free patients at week 2, in correlation with voiding/postvoiding symptoms. In patients with low education level, there was a significant decrease in IPSS at 4 and 8 weeks compared to pre-biopsy (p=0.031 and p=0.035, respectively). IPSS changes were not associated with prostate volume. Quality of life was significantly reduced in the early period (p<0.01). Conclusion: Lower urinary system symptoms are affected negatively in the early post-biopsy period in correlation with the increase of voiding/postvoiding symptoms. The time required for remission is 15-30 days. The procedure may decrease symptoms in patients with low education level due to the placebo effect.
Authors and Affiliations
Volkan Çağlayan, Sedat Öner, Efe Önen, Sinan Avcı, Mustafa Murat Aydos, Murat Demirbaş
Keywords
Related Articles
- EP ID EP382519
- DOI 10.4274/uob.1021
- Views 86
- Downloads 0
The Effect of Sex and Age Differences on Pathology Results in Primary Bladder Cancer Patients
Objective: Bladder cancer is more frequently seen in males, whereas prognosis is usually worse in female patients. Although many factors affect the prognosis of urothelial carcinoma of bladder have been proposed, the eff...
The Presence and Thickness of Pseudocapsule after Partial Nephrectomy in Renal Cell Carcinoma
Objective: In this study, we aimed to evaluate the presence and thickness of pseudocapsule after partial nephrectomy in renal cell carcinoma (RCC) cases. Materials and Methods: A total of 100 patients who were admitted t...
Metastasis Targeted Therapies in Renal Cell Cancer
Metastatic renal cell cancer is a malignant disease and its treatment has been not been described clearly yet. These patients are generally symptomatic and resistant to current treatment modalities. Radiotherapy, chemoth...
Does Robot-assisted Surgery in Urology Has Benefits? The Current Status
Minimally invasive surgery has gradually replaced the conventional surgery with the introduction of laparoscopy. Subsequently, with intensive advertisement and marketing strategies, robot-assisted surgery became popular...
Immunotherapy in Prostate Cancer
In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (...